The mission ofthe Oncology Medical Informatics and Services (OMIS) Shared Resource is to provide centralized informatics and software support with data management and analytics services to support the Masonic Cancer Center (MCC) as well as the research projects of all of its members. OMIS develops and supports database applications to provide research data management for all clinical and basic research activities in the MCC. Services include data integration, custom reporting and data set generation, grant support, database application design, development and support, and registry creation. The OMIS Shared Resource provides a critical function not currently available through the University of Minnesota Clinical and Translational Science Institute (CTSI) or the Academic Health Center. OMIS is led by Dr. Sarah Cooley, an Assistant Professor in the Division of Hematology, Oncology, and Transplantation who also serves as the Director of Clinical Research Information (a joint appointment between the University of Minnesota CTSI and Biomedical Health Informatics program) to play a key role in helping the Academic Health Center develop system-wide processes to integrate clinical and genomic data to support translational research and clinical research and personalized medicine. The OMIS group consists of a Senior Manager and a team of 9 full-time staff including, 4 programmer/database administrators, 2 research data analysts, 1 software developer, 1 data architect, and 1 informatics project manager. OMIS provides consultation free of charge to all MCC members to help prepare the informatics resource sections for grant applications and to provide initial cost estimates for other informatics projects. In addition to supporting the administrative needs ofthe MCC, the Resource supports significant database applications used by the Translational Therapy Laboratory (MSC-LIMS), the Clinical Trials Office (OnCore), and the Transplant Biology and Therapy Research Program (BMT Database). The OMIS Resource also supports NIH-funded projects from researchers from 3 of the MCC Research Programs and projects funded by other sources in 2 additional Research Programs. The services and expertise provided by this Shared Resource are critical to the clinical research mission of the MCC.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Center Core Grants (P30)
Project #
Application #
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Minnesota Twin Cities
United States
Zip Code
How, Joan; Vij, Kiran R; Ebadi, Maryam et al. (2018) Prognostic value of prior consolidation in acute myeloid leukemia patients undergoing hematopoietic cell transplantation in minimal residual disease-negative first complete remission. Am J Hematol 93:E381-E383
Ustun, C; Brunstein, C; DeFor, T et al. (2018) Importance of conditioning regimen intensity, MRD positivity, and KIR ligand mismatch in UCB transplantation. Bone Marrow Transplant 53:97-100
Williams, Shelly M; Sumstad, Darin; Kadidlo, Diane et al. (2018) Clinical-scale production of cGMP compliant CD3/CD19 cell-depleted NK cells in the evolution of NK cell immunotherapy at a single institution. Transfusion 58:1458-1467
Kaizer, Alexander M; Hobbs, Brian P; Koopmeiners, Joseph S (2018) A multi-source adaptive platform design for testing sequential combinatorial therapeutic strategies. Biometrics 74:1082-1094
Li, Danni; Huang, Fangying; Zhao, Yingchun et al. (2018) Plasma lipoproteome in Alzheimer's disease: a proof-of-concept study. Clin Proteomics 15:31
Sperduto, Paul W; Deegan, Brian J; Li, Jing et al. (2018) Estimating survival for renal cell carcinoma patients with brain metastases: an update of the Renal Graded Prognostic Assessment tool. Neuro Oncol 20:1652-1660
Yun, Byeong Hwa; Bellamri, Medjda; Rosenquist, Thomas A et al. (2018) Method for Biomonitoring DNA Adducts in Exfoliated Urinary Cells by Mass Spectrometry. Anal Chem 90:9943-9950
Hwa Yun, Byeong; Guo, Jingshu; Bellamri, Medjda et al. (2018) DNA adducts: Formation, biological effects, and new biospecimens for mass spectrometric measurements in humans. Mass Spectrom Rev :
Owen, David L; Mahmud, Shawn A; Vang, Kieng B et al. (2018) Identification of Cellular Sources of IL-2 Needed for Regulatory T Cell Development and Homeostasis. J Immunol 200:3926-3933
Rashidi, Armin; Shanley, Ryan; Yohe, Sophia L et al. (2018) Association between recipient TNF rs361525 and acute GVHD: results from analysis of BMT CTN-0201 samples. Bone Marrow Transplant 53:1069-1071

Showing the most recent 10 out of 1013 publications